Cargando…

Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD

Detalles Bibliográficos
Autores principales:	Sharma, Shilpa, Hanudel, Mark R., Ix, Joachim H., Salusky, Isidro B., Ganz, Tomas, Nguyen, Kim-Lien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895593/ https://www.ncbi.nlm.nih.gov/pubmed/31844812 http://dx.doi.org/10.1016/j.ekir.2019.07.022

Ejemplares similares

The Authors Reply
por: Sharma, Shilpa, et al.
Publicado: (2020)

The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment
por: Nie, Jingwen, et al.
Publicado: (2021)

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019)

Mechanism of Action and Clinical Attributes of Auryxia(®) (Ferric Citrate)
por: Ganz, Tomas, et al.
Publicado: (2019)

Elevated Fibroblast Growth Factor 23 and Decreased Klotho Levels Are Associated With Diastolic Dysfunction in CKD G4–5D Patients
por: Milovanova, Ludmila Yu, et al.
Publicado: (2020)

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling
por: Czaya, Brian, et al.
Publicado: (2022)

Fibroblast Growth Factor–23 and Cardiac Structure and Function
por: Agarwal, Isha, et al.
Publicado: (2014)

FGF-23: More Than a Regulator of Renal Phosphate Handling?
por: Jüppner, Harald, et al.
Publicado: (2010)

Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation
por: Alsaied, Tarek, et al.
Publicado: (2020)

Lower Mortality in Living Kidney Donors With ESRD Versus Matched Nondonors With ESRD
por: Muzaale, Abimereki D.
Publicado: (2018)

Early diastolic filling dynamics in diastolic dysfunction
por: King, Gerard J, et al.
Publicado: (2003)

Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study
por: Drew, David A., et al.
Publicado: (2020)

Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients
por: Sirimongkolchaiyakul, Ornatcha, et al.
Publicado: (2022)

Iron status in ESRD patients
por: Wiwanitkit, V.
Publicado: (2011)

The Tragedy of Having ESRD in Mexico
por: Garcia-Garcia, Guillermo, et al.
Publicado: (2018)

Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor‐23
por: Ng, Nicholas Beng Hui, et al.
Publicado: (2022)

Sepsis-associated diastolic dysfunction without elevated plasma B-type natriuretic peptide
por: Sturgess, DJ, et al.
Publicado: (2008)

High Macrophage Densities in Native Kidney Biopsies Correlate With Renal Dysfunction and Promote ESRD
por: Pfenning, Maren B., et al.
Publicado: (2022)

Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome
por: Hanudel, Mark R., et al.
Publicado: (2019)

Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2020)

Managing Diastolic Dysfunction Perioperatively
por: Cios, Theodore J., et al.
Publicado: (2022)

Protein Nutrition and Malnutrition in CKD and ESRD
por: Zha, Yan, et al.
Publicado: (2017)

Identification of ESRD in Cardiovascular Procedural Databases
por: Charytan, David M., et al.
Publicado: (2019)

COVID-19 infection recurrence in ESRD
por: Onuigbo, Macaulay A. C.
Publicado: (2022)

Prognostic value of right ventricular diastolic dysfunction in patients with inferior ST-elevated myocardial infarction
por: El Amrawy, Ahmed Mahmoud, et al.
Publicado: (2023)

Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension
por: Lin, Yao, et al.
Publicado: (2019)

Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
por: Galderisi, Maurizio
Publicado: (2005)

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction
por: Voors, Adriaan A., et al.
Publicado: (2010)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure
por: Schwarz, Ernst R, et al.
Publicado: (2010)

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1
por: Lee, Jung Eun, et al.
Publicado: (2013)

Diastolic dysfunction in septic shock is an independent predictor of elevated B-type natriuretic peptide and hospital mortality
por: Sturgess, D, et al.
Publicado: (2010)

Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders
por: Dinh, Wilfried, et al.
Publicado: (2009)

Diastolic but not systolic dysfunction is associated with troponin and N-terminal pro-brain natriuretic peptide elevation in sepsis
por: Landesberg, G, et al.
Publicado: (2009)

Diastolic dysfunction and chronic kidney disease
por: Cho, Goo-Yeong
Publicado: (2013)

Predictors of diastolic dysfunction in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2015)

Cardiac macrophages promote diastolic dysfunction
por: Hulsmans, Maarten, et al.
Publicado: (2018)

Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
por: Chou, Ruey-Hsing, et al.
Publicado: (2016)

Renal Bone Disease Among Patients With ESRD
por: Beladi Mousavi, Seyed Seifollah, et al.
Publicado: (2013)

Patient Selection in the ESRD Managed Care Demonstration
por: Shapiro, Jennifer R., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_qkrjr7eqrhhglr6dl0dvlit69d